Username:

Password:


 
ABOUT HIV PREVENTION TREATMENT NEWS COMMUNITY ABOUT US EN ESPAÑOL POZ MAGAZINE

 

 

July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007

emailrssprint

July 31, 2007

NJ Needle Exchange Arrives—With Empty Pockets

The state of New Jersey approved needle exchange pilot projects this morning in four HIV-ravaged cities: Atlantic City, Camden, Newark and Paterson. The announcement was good news for New Jersey, the very last state in the nation to permit the sale or distribution of syringes, but some Newark officials were perturbed to find no cash attached to the approvals.

Today’s announcement comes seven months after Senator Jon Corzine signed a bill legalizing needle exchange programs and invited cities to submit proposals. Newark, the city with the highest rate of HIV in the state, proposed a $1.2 million program aimed at reaching 300 injection drug users in its first year, and officials believed state approval would mean state funding.

Not so, says the state. “From the start, the legislation made it clear that no state funding was attached,” Tom Slater, Communications Director for the New Jersey Department of Health and Senior Services, told POZ.  So how will the cities be able to implement these pilot programs without state funds? According to Slater, the city of Camden has already partnered with private agencies and is therefore expected to be the first program up and running.

Needle exchange is much needed in New Jersey, with roughly half of the state’s HIV cases linked to people who used injection drugs or who have had sex with IV drug users—about twice the national average. The state ranks fifth in the U.S. for total cases of HIV.

emailrssprint


[Go to top]







Michelle



Glenn



Hilary





[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. terms of use and your privacy